Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease
Top Cited Papers
- 21 July 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 2 (41) , 41ra51
- https://doi.org/10.1126/scitranslmed.3001012
Abstract
Celiac disease is a genetic condition that results in a debilitating immune reaction in the gut to antigens in grain. The antigenic peptides recognized by the T cells that cause this disease are incompletely defined. Our understanding of the epitopes of pathogenic CD4+ T cells is based primarily on responses shown by intestinal T-cells in vitro to hydrolysates or polypeptides of gluten, the causative antigen. A protease-resistant 33-amino acid peptide from wheat α-gliadin is the immunodominant antigen, but little is known about the spectrum of T cell epitopes in rye and barley or the hierarchy of immunodominance and consistency of recognition of T-cell epitopes in vivo. We induced polyclonal gluten-specific T cells in the peripheral blood of celiac patients by feeding them cereal and performed a comprehensive, unbiased analysis of responses to all celiac toxic prolamins, a class of plant storage protein. The peptides that stimulated T cells were the same among patients who ate the same cereal, but were different after wheat, barley and rye ingestion. Unexpectedly, a sequence from ω-gliadin (wheat) and C-hordein (barley) but not α-gliadin was immunodominant regardless of the grain consumed. Furthermore, T cells specific for just three peptides accounted for the majority of gluten-specific T cells, and their recognition of gluten peptides was highly redundant. Our findings show that pathogenic T cells in celiac disease show limited diversity, and therefore suggest that peptide-based therapeutics for this disease and potentially other strongly HLA-restricted immune diseases should be possible.This publication has 54 references indexed in Scilit:
- Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppressionThe Journal of Experimental Medicine, 2009
- Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten‐free dietAlimentary Pharmacology & Therapeutics, 2009
- Intestinal T Cell Responses to Gluten Peptides Are Largely Heterogeneous: Implications for a Peptide-Based Therapy in Celiac DiseaseThe Journal of Immunology, 2009
- Therapeutic peptide vaccines for treatment of autoimmune diseasesImmunology Letters, 2009
- Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue InjuryPLOS ONE, 2008
- Induction of antigen-specific regulatory T cells in wild-type mice: Visualization and targets of suppressionProceedings of the National Academy of Sciences, 2008
- HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac diseaseJournal of Clinical Investigation, 2006
- The Molecular Basis for Oat Intolerance in Patients with Celiac DiseasePLoS Medicine, 2004
- Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- HLA‐DQB1 and ‐DQA1 typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hoursTissue Antigens, 1993